Positive pivotal top-line data demonstrates 20-valent pneumococcal conjugate vaccine candidate (20vPnC), if approved, can likely help protect against all 20 vaccine serotypes in three-dose series and potentially offer the broadest… Read More
Health Research BC’s funding for 71 researchers through the 2022 Scholar and Research Trainee competitions will help develop, attract and retain BC’s best and brightest health researchers and support the… Read More
Vancouver biotech anchor AbCellera has broken ground at the Mount Pleasant address that will soon be home to Phase 2 of the Vancouver-grown company’s 380,000-square-foot global headquarters. AbCellera’s leadership team were joined… Read More
Vancouver, BC — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development and manufacturing of rare cannabinoids, today announced the closing of its previously… Read More
CHMP recommendation based on favorable data from Omicron-adapted vaccines The Omicron BA.4/BA.5 bivalent COVID-19 booster vaccine combines 15-ug of mRNA encoding the wild-type spike protein of SARS-CoV-2 in the Original… Read More
